O1.7. PROTEOMIC ANALYSIS OF BLOOD BASED SAMPLES FROM THE OPTiMiSE (OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE) STUDY POINT TOWARDS COMPLEMENT PATHWAY PROTEIN CHANGES

BACKGROUND: The OPTiMiSE (Optimization of Treatment and Management of Schizophrenia in Europe) trial may help in the identification of predictors of treatment response. Medication naïve patients with first episode schizophrenia or schizophreniform disorder were enrolled in the study and treated open...

Descripción completa

Detalles Bibliográficos
Autores principales: Föcking, Melanie, Pollak, Thomas, Dicker, Patrick, Cagney, Gerard, Winter, Inge, Kahn, Rene, McGuire, Philip, Cotter, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888760/
http://dx.doi.org/10.1093/schbul/sby015.189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888760/
http://dx.doi.org/10.1093/schbul/sby015.189

Ejemplares similares